Alogliptin and pioglitazone
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Alogliptin and pioglitazone, covering 2013-01-25 to 2024-06-28. Get the full timeline:
Most recent: FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)